nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—ABCB1—epilepsy syndrome	0.18	1	CbGaD
Tolvaptan—ABCB1—Levetiracetam—epilepsy syndrome	0.0435	0.0906	CbGbCtD
Tolvaptan—ABCB1—Clobazam—epilepsy syndrome	0.0301	0.0628	CbGbCtD
Tolvaptan—ABCB1—Lamotrigine—epilepsy syndrome	0.029	0.0605	CbGbCtD
Tolvaptan—ABCB1—Carbamazepine—epilepsy syndrome	0.025	0.0521	CbGbCtD
Tolvaptan—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0238	0.0497	CbGbCtD
Tolvaptan—ABCB1—Phenytoin—epilepsy syndrome	0.0224	0.0467	CbGbCtD
Tolvaptan—CYP3A4—Trimethadione—epilepsy syndrome	0.0221	0.0462	CbGbCtD
Tolvaptan—CYP3A4—Felbamate—epilepsy syndrome	0.0221	0.0462	CbGbCtD
Tolvaptan—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0208	0.0434	CbGbCtD
Tolvaptan—ABCB1—Phenobarbital—epilepsy syndrome	0.02	0.0416	CbGbCtD
Tolvaptan—ABCB1—Midazolam—epilepsy syndrome	0.0197	0.041	CbGbCtD
Tolvaptan—ABCB1—Diazepam—epilepsy syndrome	0.0189	0.0395	CbGbCtD
Tolvaptan—CYP3A4—Clonazepam—epilepsy syndrome	0.0188	0.0393	CbGbCtD
Tolvaptan—CYP3A4—Clobazam—epilepsy syndrome	0.018	0.0376	CbGbCtD
Tolvaptan—CYP3A4—Rufinamide—epilepsy syndrome	0.0153	0.032	CbGbCtD
Tolvaptan—CYP3A4—Carbamazepine—epilepsy syndrome	0.015	0.0312	CbGbCtD
Tolvaptan—CYP3A4—Primidone—epilepsy syndrome	0.014	0.0291	CbGbCtD
Tolvaptan—CYP3A4—Phenytoin—epilepsy syndrome	0.0134	0.028	CbGbCtD
Tolvaptan—CYP3A4—Propofol—epilepsy syndrome	0.0125	0.0261	CbGbCtD
Tolvaptan—CYP3A4—Phenobarbital—epilepsy syndrome	0.012	0.0249	CbGbCtD
Tolvaptan—CYP3A4—Acetazolamide—epilepsy syndrome	0.012	0.0249	CbGbCtD
Tolvaptan—CYP3A4—Midazolam—epilepsy syndrome	0.0118	0.0246	CbGbCtD
Tolvaptan—CYP3A4—Diazepam—epilepsy syndrome	0.0113	0.0236	CbGbCtD
Tolvaptan—CYP3A4—Zonisamide—epilepsy syndrome	0.0111	0.0231	CbGbCtD
Tolvaptan—CYP3A4—Valproic Acid—epilepsy syndrome	0.00893	0.0186	CbGbCtD
Tolvaptan—CYP3A4—Topiramate—epilepsy syndrome	0.00806	0.0168	CbGbCtD
Tolvaptan—Zafirlukast—ABCG2—epilepsy syndrome	0.000787	0.217	CrCbGaD
Tolvaptan—Vismodegib—ABCG2—epilepsy syndrome	0.000666	0.184	CrCbGaD
Tolvaptan—Zafirlukast—CYP2C19—epilepsy syndrome	0.000619	0.171	CrCbGaD
Tolvaptan—Vismodegib—CYP2C19—epilepsy syndrome	0.000524	0.145	CrCbGaD
Tolvaptan—Zafirlukast—CYP2D6—epilepsy syndrome	0.000459	0.127	CrCbGaD
Tolvaptan—Vismodegib—ALB—epilepsy syndrome	0.000291	0.0802	CrCbGaD
Tolvaptan—Vismodegib—ABCB1—epilepsy syndrome	0.000277	0.0766	CrCbGaD
Tolvaptan—Feeling abnormal—Diazepam—epilepsy syndrome	0.000171	0.00087	CcSEcCtD
Tolvaptan—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.000171	0.000869	CcSEcCtD
Tolvaptan—Decreased appetite—Zonisamide—epilepsy syndrome	0.000171	0.000869	CcSEcCtD
Tolvaptan—Diarrhoea—Acetazolamide—epilepsy syndrome	0.000171	0.000869	CcSEcCtD
Tolvaptan—Shock—Lamotrigine—epilepsy syndrome	0.000171	0.000869	CcSEcCtD
Tolvaptan—Nervous system disorder—Lamotrigine—epilepsy syndrome	0.000171	0.000866	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Zonisamide—epilepsy syndrome	0.00017	0.000863	CcSEcCtD
Tolvaptan—Malnutrition—Valproic Acid—epilepsy syndrome	0.000169	0.00086	CcSEcCtD
Tolvaptan—Constipation—Zonisamide—epilepsy syndrome	0.000168	0.000855	CcSEcCtD
Tolvaptan—Hypersensitivity—Midazolam—epilepsy syndrome	0.000168	0.00085	CcSEcCtD
Tolvaptan—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000167	0.000847	CcSEcCtD
Tolvaptan—Nausea—Clobazam—epilepsy syndrome	0.000167	0.000846	CcSEcCtD
Tolvaptan—Asthenia—Propofol—epilepsy syndrome	0.000167	0.000846	CcSEcCtD
Tolvaptan—Dysgeusia—Valproic Acid—epilepsy syndrome	0.000166	0.000842	CcSEcCtD
Tolvaptan—Feeling abnormal—Felbamate—epilepsy syndrome	0.000166	0.000842	CcSEcCtD
Tolvaptan—Anorexia—Lamotrigine—epilepsy syndrome	0.000166	0.000842	CcSEcCtD
Tolvaptan—Dizziness—Acetazolamide—epilepsy syndrome	0.000165	0.00084	CcSEcCtD
Tolvaptan—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000165	0.000839	CcSEcCtD
Tolvaptan—Decreased appetite—Clonazepam—epilepsy syndrome	0.000165	0.000838	CcSEcCtD
Tolvaptan—Pruritus—Propofol—epilepsy syndrome	0.000164	0.000834	CcSEcCtD
Tolvaptan—Decreased appetite—Phenytoin—epilepsy syndrome	0.000164	0.000832	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	0.000164	0.000832	CcSEcCtD
Tolvaptan—Cardiac disorder—Pregabalin—epilepsy syndrome	0.000163	0.000829	CcSEcCtD
Tolvaptan—Asthenia—Midazolam—epilepsy syndrome	0.000163	0.000828	CcSEcCtD
Tolvaptan—Decreased appetite—Oxcarbazepine—epilepsy syndrome	0.000163	0.000828	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	0.000163	0.000826	CcSEcCtD
Tolvaptan—Constipation—Clonazepam—epilepsy syndrome	0.000162	0.000824	CcSEcCtD
Tolvaptan—Feeling abnormal—Zonisamide—epilepsy syndrome	0.000162	0.000824	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	0.000162	0.000822	CcSEcCtD
Tolvaptan—Constipation—Phenytoin—epilepsy syndrome	0.000161	0.000818	CcSEcCtD
Tolvaptan—Asthenia—Levetiracetam—epilepsy syndrome	0.000161	0.000817	CcSEcCtD
Tolvaptan—Pruritus—Midazolam—epilepsy syndrome	0.000161	0.000816	CcSEcCtD
Tolvaptan—Constipation—Oxcarbazepine—epilepsy syndrome	0.00016	0.000814	CcSEcCtD
Tolvaptan—Angiopathy—Pregabalin—epilepsy syndrome	0.00016	0.00081	CcSEcCtD
Tolvaptan—Urinary tract disorder—Gabapentin—epilepsy syndrome	0.000159	0.000808	CcSEcCtD
Tolvaptan—Body temperature increased—Felbamate—epilepsy syndrome	0.000159	0.000807	CcSEcCtD
Tolvaptan—Diarrhoea—Propofol—epilepsy syndrome	0.000159	0.000807	CcSEcCtD
Tolvaptan—Immune system disorder—Pregabalin—epilepsy syndrome	0.000159	0.000806	CcSEcCtD
Tolvaptan—Pruritus—Levetiracetam—epilepsy syndrome	0.000159	0.000806	CcSEcCtD
Tolvaptan—Mediastinal disorder—Pregabalin—epilepsy syndrome	0.000159	0.000805	CcSEcCtD
Tolvaptan—Connective tissue disorder—Gabapentin—epilepsy syndrome	0.000159	0.000804	CcSEcCtD
Tolvaptan—Urethral disorder—Gabapentin—epilepsy syndrome	0.000158	0.000802	CcSEcCtD
Tolvaptan—Ill-defined disorder—Valproic Acid—epilepsy syndrome	0.000157	0.000798	CcSEcCtD
Tolvaptan—Headache—Acetazolamide—epilepsy syndrome	0.000157	0.000795	CcSEcCtD
Tolvaptan—Pollakiuria—Topiramate—epilepsy syndrome	0.000157	0.000795	CcSEcCtD
Tolvaptan—Decreased appetite—Carbamazepine—epilepsy syndrome	0.000157	0.000794	CcSEcCtD
Tolvaptan—Feeling abnormal—Clonazepam—epilepsy syndrome	0.000156	0.000794	CcSEcCtD
Tolvaptan—Body temperature increased—Zonisamide—epilepsy syndrome	0.000156	0.00079	CcSEcCtD
Tolvaptan—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000156	0.00079	CcSEcCtD
Tolvaptan—Asthenia—Fosphenytoin—epilepsy syndrome	0.000155	0.000789	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	0.000155	0.000789	CcSEcCtD
Tolvaptan—Feeling abnormal—Phenytoin—epilepsy syndrome	0.000155	0.000789	CcSEcCtD
Tolvaptan—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	0.000155	0.000784	CcSEcCtD
Tolvaptan—Constipation—Carbamazepine—epilepsy syndrome	0.000154	0.000781	CcSEcCtD
Tolvaptan—Dizziness—Propofol—epilepsy syndrome	0.000154	0.00078	CcSEcCtD
Tolvaptan—Diarrhoea—Levetiracetam—epilepsy syndrome	0.000154	0.00078	CcSEcCtD
Tolvaptan—Pruritus—Fosphenytoin—epilepsy syndrome	0.000153	0.000778	CcSEcCtD
Tolvaptan—Hypersensitivity—Diazepam—epilepsy syndrome	0.000153	0.000777	CcSEcCtD
Tolvaptan—Malnutrition—Pregabalin—epilepsy syndrome	0.000153	0.000777	CcSEcCtD
Tolvaptan—Hyperglycaemia—Topiramate—epilepsy syndrome	0.000153	0.000776	CcSEcCtD
Tolvaptan—Malaise—Valproic Acid—epilepsy syndrome	0.000153	0.000775	CcSEcCtD
Tolvaptan—Asthenia—Vigabatrin—epilepsy syndrome	0.000152	0.000769	CcSEcCtD
Tolvaptan—Decreased appetite—Lamotrigine—epilepsy syndrome	0.000151	0.000767	CcSEcCtD
Tolvaptan—Dizziness—Midazolam—epilepsy syndrome	0.00015	0.000763	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	0.00015	0.000762	CcSEcCtD
Tolvaptan—Body temperature increased—Clonazepam—epilepsy syndrome	0.00015	0.000762	CcSEcCtD
Tolvaptan—Dysgeusia—Pregabalin—epilepsy syndrome	0.00015	0.000761	CcSEcCtD
Tolvaptan—Cardiac disorder—Gabapentin—epilepsy syndrome	0.00015	0.00076	CcSEcCtD
Tolvaptan—Pruritus—Vigabatrin—epilepsy syndrome	0.000149	0.000758	CcSEcCtD
Tolvaptan—Asthenia—Diazepam—epilepsy syndrome	0.000149	0.000757	CcSEcCtD
Tolvaptan—Body temperature increased—Phenytoin—epilepsy syndrome	0.000149	0.000757	CcSEcCtD
Tolvaptan—Constipation—Lamotrigine—epilepsy syndrome	0.000149	0.000755	CcSEcCtD
Tolvaptan—Renal failure—Topiramate—epilepsy syndrome	0.000149	0.000754	CcSEcCtD
Tolvaptan—Nausea—Acetazolamide—epilepsy syndrome	0.000149	0.000754	CcSEcCtD
Tolvaptan—Dizziness—Levetiracetam—epilepsy syndrome	0.000148	0.000753	CcSEcCtD
Tolvaptan—Feeling abnormal—Carbamazepine—epilepsy syndrome	0.000148	0.000753	CcSEcCtD
Tolvaptan—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000148	0.000753	CcSEcCtD
Tolvaptan—Diarrhoea—Fosphenytoin—epilepsy syndrome	0.000148	0.000752	CcSEcCtD
Tolvaptan—Pruritus—Diazepam—epilepsy syndrome	0.000147	0.000747	CcSEcCtD
Tolvaptan—Immune system disorder—Gabapentin—epilepsy syndrome	0.000146	0.000739	CcSEcCtD
Tolvaptan—Headache—Propofol—epilepsy syndrome	0.000146	0.000739	CcSEcCtD
Tolvaptan—Mediastinal disorder—Gabapentin—epilepsy syndrome	0.000145	0.000738	CcSEcCtD
Tolvaptan—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000145	0.000737	CcSEcCtD
Tolvaptan—Diarrhoea—Vigabatrin—epilepsy syndrome	0.000145	0.000733	CcSEcCtD
Tolvaptan—Asthenia—Felbamate—epilepsy syndrome	0.000144	0.000733	CcSEcCtD
Tolvaptan—Feeling abnormal—Lamotrigine—epilepsy syndrome	0.000143	0.000728	CcSEcCtD
Tolvaptan—Dizziness—Fosphenytoin—epilepsy syndrome	0.000143	0.000727	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—epilepsy syndrome	0.000143	0.000727	CcSEcCtD
Tolvaptan—Discomfort—Valproic Acid—epilepsy syndrome	0.000143	0.000723	CcSEcCtD
Tolvaptan—Headache—Midazolam—epilepsy syndrome	0.000142	0.000723	CcSEcCtD
Tolvaptan—Pruritus—Felbamate—epilepsy syndrome	0.000142	0.000723	CcSEcCtD
Tolvaptan—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000142	0.000722	CcSEcCtD
Tolvaptan—Diarrhoea—Diazepam—epilepsy syndrome	0.000142	0.000722	CcSEcCtD
Tolvaptan—Ill-defined disorder—Pregabalin—epilepsy syndrome	0.000142	0.000721	CcSEcCtD
Tolvaptan—Asthenia—Zonisamide—epilepsy syndrome	0.000141	0.000717	CcSEcCtD
Tolvaptan—Dry mouth—Valproic Acid—epilepsy syndrome	0.000141	0.000716	CcSEcCtD
Tolvaptan—Headache—Levetiracetam—epilepsy syndrome	0.000141	0.000714	CcSEcCtD
Tolvaptan—Malnutrition—Gabapentin—epilepsy syndrome	0.00014	0.000713	CcSEcCtD
Tolvaptan—Hypersensitivity—Clonazepam—epilepsy syndrome	0.00014	0.00071	CcSEcCtD
Tolvaptan—Dizziness—Vigabatrin—epilepsy syndrome	0.00014	0.000709	CcSEcCtD
Tolvaptan—Pruritus—Zonisamide—epilepsy syndrome	0.000139	0.000707	CcSEcCtD
Tolvaptan—Hypersensitivity—Phenytoin—epilepsy syndrome	0.000139	0.000705	CcSEcCtD
Tolvaptan—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.000138	0.000702	CcSEcCtD
Tolvaptan—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.000138	0.000701	CcSEcCtD
Tolvaptan—Malaise—Pregabalin—epilepsy syndrome	0.000138	0.000701	CcSEcCtD
Tolvaptan—Nausea—Propofol—epilepsy syndrome	0.000138	0.0007	CcSEcCtD
Tolvaptan—Diarrhoea—Felbamate—epilepsy syndrome	0.000138	0.000699	CcSEcCtD
Tolvaptan—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000138	0.000698	CcSEcCtD
Tolvaptan—Dysgeusia—Gabapentin—epilepsy syndrome	0.000138	0.000698	CcSEcCtD
Tolvaptan—Dizziness—Diazepam—epilepsy syndrome	0.000138	0.000698	CcSEcCtD
Tolvaptan—Syncope—Pregabalin—epilepsy syndrome	0.000137	0.000697	CcSEcCtD
Tolvaptan—Asthenia—Clonazepam—epilepsy syndrome	0.000136	0.000691	CcSEcCtD
Tolvaptan—Headache—Fosphenytoin—epilepsy syndrome	0.000136	0.000689	CcSEcCtD
Tolvaptan—Nervous system disorder—Valproic Acid—epilepsy syndrome	0.000136	0.000688	CcSEcCtD
Tolvaptan—Asthenia—Phenytoin—epilepsy syndrome	0.000135	0.000687	CcSEcCtD
Tolvaptan—Nausea—Midazolam—epilepsy syndrome	0.000135	0.000685	CcSEcCtD
Tolvaptan—Diarrhoea—Zonisamide—epilepsy syndrome	0.000135	0.000684	CcSEcCtD
Tolvaptan—Loss of consciousness—Pregabalin—epilepsy syndrome	0.000135	0.000683	CcSEcCtD
Tolvaptan—Asthenia—Oxcarbazepine—epilepsy syndrome	0.000135	0.000683	CcSEcCtD
Tolvaptan—Pruritus—Clonazepam—epilepsy syndrome	0.000134	0.000682	CcSEcCtD
Tolvaptan—Skin disorder—Valproic Acid—epilepsy syndrome	0.000134	0.000681	CcSEcCtD
Tolvaptan—Urinary tract disorder—Topiramate—epilepsy syndrome	0.000134	0.00068	CcSEcCtD
Tolvaptan—Pruritus—Phenytoin—epilepsy syndrome	0.000133	0.000677	CcSEcCtD
Tolvaptan—Connective tissue disorder—Topiramate—epilepsy syndrome	0.000133	0.000677	CcSEcCtD
Tolvaptan—Nausea—Levetiracetam—epilepsy syndrome	0.000133	0.000677	CcSEcCtD
Tolvaptan—Dizziness—Felbamate—epilepsy syndrome	0.000133	0.000675	CcSEcCtD
Tolvaptan—Urethral disorder—Topiramate—epilepsy syndrome	0.000133	0.000675	CcSEcCtD
Tolvaptan—Pruritus—Oxcarbazepine—epilepsy syndrome	0.000133	0.000674	CcSEcCtD
Tolvaptan—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000133	0.000673	CcSEcCtD
Tolvaptan—Headache—Vigabatrin—epilepsy syndrome	0.000132	0.000671	CcSEcCtD
Tolvaptan—Anorexia—Valproic Acid—epilepsy syndrome	0.000132	0.000669	CcSEcCtD
Tolvaptan—Ill-defined disorder—Gabapentin—epilepsy syndrome	0.00013	0.000661	CcSEcCtD
Tolvaptan—Dizziness—Zonisamide—epilepsy syndrome	0.00013	0.000661	CcSEcCtD
Tolvaptan—Headache—Diazepam—epilepsy syndrome	0.00013	0.000661	CcSEcCtD
Tolvaptan—Diarrhoea—Clonazepam—epilepsy syndrome	0.00013	0.000659	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	0.000129	0.000657	CcSEcCtD
Tolvaptan—Asthenia—Carbamazepine—epilepsy syndrome	0.000129	0.000655	CcSEcCtD
Tolvaptan—Diarrhoea—Phenytoin—epilepsy syndrome	0.000129	0.000655	CcSEcCtD
Tolvaptan—Discomfort—Pregabalin—epilepsy syndrome	0.000129	0.000654	CcSEcCtD
Tolvaptan—Nausea—Fosphenytoin—epilepsy syndrome	0.000129	0.000653	CcSEcCtD
Tolvaptan—Diarrhoea—Oxcarbazepine—epilepsy syndrome	0.000128	0.000651	CcSEcCtD
Tolvaptan—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000128	0.00065	CcSEcCtD
Tolvaptan—Dry mouth—Pregabalin—epilepsy syndrome	0.000128	0.000647	CcSEcCtD
Tolvaptan—Pruritus—Carbamazepine—epilepsy syndrome	0.000127	0.000646	CcSEcCtD
Tolvaptan—Malaise—Gabapentin—epilepsy syndrome	0.000127	0.000643	CcSEcCtD
Tolvaptan—Headache—Felbamate—epilepsy syndrome	0.000126	0.00064	CcSEcCtD
Tolvaptan—Cardiac disorder—Topiramate—epilepsy syndrome	0.000126	0.000639	CcSEcCtD
Tolvaptan—Syncope—Gabapentin—epilepsy syndrome	0.000126	0.000639	CcSEcCtD
Tolvaptan—Dizziness—Clonazepam—epilepsy syndrome	0.000126	0.000637	CcSEcCtD
Tolvaptan—Nausea—Vigabatrin—epilepsy syndrome	0.000125	0.000637	CcSEcCtD
Tolvaptan—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000125	0.000634	CcSEcCtD
Tolvaptan—Asthenia—Lamotrigine—epilepsy syndrome	0.000125	0.000633	CcSEcCtD
Tolvaptan—Dizziness—Phenytoin—epilepsy syndrome	0.000125	0.000633	CcSEcCtD
Tolvaptan—Dizziness—Oxcarbazepine—epilepsy syndrome	0.000124	0.00063	CcSEcCtD
Tolvaptan—Nausea—Diazepam—epilepsy syndrome	0.000124	0.000627	CcSEcCtD
Tolvaptan—Loss of consciousness—Gabapentin—epilepsy syndrome	0.000123	0.000626	CcSEcCtD
Tolvaptan—Headache—Zonisamide—epilepsy syndrome	0.000123	0.000626	CcSEcCtD
Tolvaptan—Diarrhoea—Carbamazepine—epilepsy syndrome	0.000123	0.000625	CcSEcCtD
Tolvaptan—Angiopathy—Topiramate—epilepsy syndrome	0.000123	0.000625	CcSEcCtD
Tolvaptan—Pruritus—Lamotrigine—epilepsy syndrome	0.000123	0.000625	CcSEcCtD
Tolvaptan—Shock—Pregabalin—epilepsy syndrome	0.000123	0.000624	CcSEcCtD
Tolvaptan—Immune system disorder—Topiramate—epilepsy syndrome	0.000123	0.000622	CcSEcCtD
Tolvaptan—Nervous system disorder—Pregabalin—epilepsy syndrome	0.000123	0.000622	CcSEcCtD
Tolvaptan—Mediastinal disorder—Topiramate—epilepsy syndrome	0.000122	0.000621	CcSEcCtD
Tolvaptan—Skin disorder—Pregabalin—epilepsy syndrome	0.000121	0.000616	CcSEcCtD
Tolvaptan—Decreased appetite—Valproic Acid—epilepsy syndrome	0.00012	0.00061	CcSEcCtD
Tolvaptan—Nausea—Felbamate—epilepsy syndrome	0.00012	0.000607	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	0.000119	0.000606	CcSEcCtD
Tolvaptan—Anorexia—Pregabalin—epilepsy syndrome	0.000119	0.000605	CcSEcCtD
Tolvaptan—Dizziness—Carbamazepine—epilepsy syndrome	0.000119	0.000604	CcSEcCtD
Tolvaptan—Diarrhoea—Lamotrigine—epilepsy syndrome	0.000119	0.000604	CcSEcCtD
Tolvaptan—Headache—Clonazepam—epilepsy syndrome	0.000119	0.000604	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	0.000119	0.000603	CcSEcCtD
Tolvaptan—Constipation—Valproic Acid—epilepsy syndrome	0.000118	0.0006	CcSEcCtD
Tolvaptan—Headache—Phenytoin—epilepsy syndrome	0.000118	0.0006	CcSEcCtD
Tolvaptan—Malnutrition—Topiramate—epilepsy syndrome	0.000118	0.0006	CcSEcCtD
Tolvaptan—Discomfort—Gabapentin—epilepsy syndrome	0.000118	0.000599	CcSEcCtD
Tolvaptan—Headache—Oxcarbazepine—epilepsy syndrome	0.000118	0.000596	CcSEcCtD
Tolvaptan—Nausea—Zonisamide—epilepsy syndrome	0.000117	0.000594	CcSEcCtD
Tolvaptan—Dry mouth—Gabapentin—epilepsy syndrome	0.000117	0.000593	CcSEcCtD
Tolvaptan—Dysgeusia—Topiramate—epilepsy syndrome	0.000116	0.000587	CcSEcCtD
Tolvaptan—Dizziness—Lamotrigine—epilepsy syndrome	0.000115	0.000584	CcSEcCtD
Tolvaptan—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000115	0.000582	CcSEcCtD
Tolvaptan—Feeling abnormal—Valproic Acid—epilepsy syndrome	0.000114	0.000578	CcSEcCtD
Tolvaptan—Nausea—Clonazepam—epilepsy syndrome	0.000113	0.000572	CcSEcCtD
Tolvaptan—Headache—Carbamazepine—epilepsy syndrome	0.000113	0.000572	CcSEcCtD
Tolvaptan—Shock—Gabapentin—epilepsy syndrome	0.000113	0.000572	CcSEcCtD
Tolvaptan—Nervous system disorder—Gabapentin—epilepsy syndrome	0.000112	0.00057	CcSEcCtD
Tolvaptan—Nausea—Phenytoin—epilepsy syndrome	0.000112	0.000568	CcSEcCtD
Tolvaptan—Nausea—Oxcarbazepine—epilepsy syndrome	0.000111	0.000565	CcSEcCtD
Tolvaptan—Skin disorder—Gabapentin—epilepsy syndrome	0.000111	0.000565	CcSEcCtD
Tolvaptan—Ill-defined disorder—Topiramate—epilepsy syndrome	0.00011	0.000556	CcSEcCtD
Tolvaptan—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000109	0.000555	CcSEcCtD
Tolvaptan—Anorexia—Gabapentin—epilepsy syndrome	0.000109	0.000554	CcSEcCtD
Tolvaptan—Headache—Lamotrigine—epilepsy syndrome	0.000109	0.000553	CcSEcCtD
Tolvaptan—Decreased appetite—Pregabalin—epilepsy syndrome	0.000109	0.000551	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	0.000108	0.000548	CcSEcCtD
Tolvaptan—Nausea—Carbamazepine—epilepsy syndrome	0.000107	0.000543	CcSEcCtD
Tolvaptan—Constipation—Pregabalin—epilepsy syndrome	0.000107	0.000542	CcSEcCtD
Tolvaptan—Malaise—Topiramate—epilepsy syndrome	0.000107	0.000541	CcSEcCtD
Tolvaptan—Syncope—Topiramate—epilepsy syndrome	0.000106	0.000538	CcSEcCtD
Tolvaptan—Loss of consciousness—Topiramate—epilepsy syndrome	0.000104	0.000527	CcSEcCtD
Tolvaptan—Nausea—Lamotrigine—epilepsy syndrome	0.000103	0.000524	CcSEcCtD
Tolvaptan—Feeling abnormal—Pregabalin—epilepsy syndrome	0.000103	0.000523	CcSEcCtD
Tolvaptan—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000102	0.000517	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	9.99e-05	0.000507	CcSEcCtD
Tolvaptan—Decreased appetite—Gabapentin—epilepsy syndrome	9.96e-05	0.000506	CcSEcCtD
Tolvaptan—Discomfort—Topiramate—epilepsy syndrome	9.94e-05	0.000504	CcSEcCtD
Tolvaptan—Asthenia—Valproic Acid—epilepsy syndrome	9.92e-05	0.000503	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	9.9e-05	0.000502	CcSEcCtD
Tolvaptan—Body temperature increased—Pregabalin—epilepsy syndrome	9.88e-05	0.000501	CcSEcCtD
Tolvaptan—Dry mouth—Topiramate—epilepsy syndrome	9.84e-05	0.000499	CcSEcCtD
Tolvaptan—Constipation—Gabapentin—epilepsy syndrome	9.8e-05	0.000497	CcSEcCtD
Tolvaptan—Pruritus—Valproic Acid—epilepsy syndrome	9.78e-05	0.000496	CcSEcCtD
Tolvaptan—Shock—Topiramate—epilepsy syndrome	9.49e-05	0.000481	CcSEcCtD
Tolvaptan—Diarrhoea—Valproic Acid—epilepsy syndrome	9.46e-05	0.00048	CcSEcCtD
Tolvaptan—Nervous system disorder—Topiramate—epilepsy syndrome	9.46e-05	0.00048	CcSEcCtD
Tolvaptan—Feeling abnormal—Gabapentin—epilepsy syndrome	9.45e-05	0.000479	CcSEcCtD
Tolvaptan—Skin disorder—Topiramate—epilepsy syndrome	9.37e-05	0.000475	CcSEcCtD
Tolvaptan—Hypersensitivity—Pregabalin—epilepsy syndrome	9.21e-05	0.000467	CcSEcCtD
Tolvaptan—Anorexia—Topiramate—epilepsy syndrome	9.19e-05	0.000466	CcSEcCtD
Tolvaptan—Dizziness—Valproic Acid—epilepsy syndrome	9.14e-05	0.000464	CcSEcCtD
Tolvaptan—Body temperature increased—Gabapentin—epilepsy syndrome	9.06e-05	0.00046	CcSEcCtD
Tolvaptan—Asthenia—Pregabalin—epilepsy syndrome	8.97e-05	0.000455	CcSEcCtD
Tolvaptan—Pruritus—Pregabalin—epilepsy syndrome	8.84e-05	0.000449	CcSEcCtD
Tolvaptan—Headache—Valproic Acid—epilepsy syndrome	8.66e-05	0.00044	CcSEcCtD
Tolvaptan—Diarrhoea—Pregabalin—epilepsy syndrome	8.55e-05	0.000434	CcSEcCtD
Tolvaptan—Hypersensitivity—Gabapentin—epilepsy syndrome	8.44e-05	0.000428	CcSEcCtD
Tolvaptan—Decreased appetite—Topiramate—epilepsy syndrome	8.38e-05	0.000425	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Topiramate—epilepsy syndrome	8.33e-05	0.000422	CcSEcCtD
Tolvaptan—Dizziness—Pregabalin—epilepsy syndrome	8.27e-05	0.000419	CcSEcCtD
Tolvaptan—Constipation—Topiramate—epilepsy syndrome	8.25e-05	0.000418	CcSEcCtD
Tolvaptan—Asthenia—Gabapentin—epilepsy syndrome	8.22e-05	0.000417	CcSEcCtD
Tolvaptan—Nausea—Valproic Acid—epilepsy syndrome	8.21e-05	0.000417	CcSEcCtD
Tolvaptan—Pruritus—Gabapentin—epilepsy syndrome	8.11e-05	0.000411	CcSEcCtD
Tolvaptan—Feeling abnormal—Topiramate—epilepsy syndrome	7.95e-05	0.000403	CcSEcCtD
Tolvaptan—Diarrhoea—Gabapentin—epilepsy syndrome	7.84e-05	0.000398	CcSEcCtD
Tolvaptan—Headache—Pregabalin—epilepsy syndrome	7.83e-05	0.000397	CcSEcCtD
Tolvaptan—Body temperature increased—Topiramate—epilepsy syndrome	7.62e-05	0.000387	CcSEcCtD
Tolvaptan—Dizziness—Gabapentin—epilepsy syndrome	7.58e-05	0.000385	CcSEcCtD
Tolvaptan—Nausea—Pregabalin—epilepsy syndrome	7.42e-05	0.000377	CcSEcCtD
Tolvaptan—Headache—Gabapentin—epilepsy syndrome	7.18e-05	0.000364	CcSEcCtD
Tolvaptan—Hypersensitivity—Topiramate—epilepsy syndrome	7.1e-05	0.00036	CcSEcCtD
Tolvaptan—Asthenia—Topiramate—epilepsy syndrome	6.92e-05	0.000351	CcSEcCtD
Tolvaptan—Pruritus—Topiramate—epilepsy syndrome	6.82e-05	0.000346	CcSEcCtD
Tolvaptan—Nausea—Gabapentin—epilepsy syndrome	6.81e-05	0.000345	CcSEcCtD
Tolvaptan—Diarrhoea—Topiramate—epilepsy syndrome	6.6e-05	0.000335	CcSEcCtD
Tolvaptan—Dizziness—Topiramate—epilepsy syndrome	6.38e-05	0.000324	CcSEcCtD
Tolvaptan—Headache—Topiramate—epilepsy syndrome	6.04e-05	0.000307	CcSEcCtD
Tolvaptan—Nausea—Topiramate—epilepsy syndrome	5.73e-05	0.000291	CcSEcCtD
Tolvaptan—AVPR1A—GPCR downstream signaling—POMC—epilepsy syndrome	2.73e-05	0.000196	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—PRKCB—epilepsy syndrome	2.73e-05	0.000196	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	2.72e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—BDKRB2—epilepsy syndrome	2.72e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CXCL12—epilepsy syndrome	2.72e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6ST—epilepsy syndrome	2.71e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—POMC—epilepsy syndrome	2.71e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—PRKCB—epilepsy syndrome	2.71e-05	0.000194	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	2.7e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6ST—epilepsy syndrome	2.69e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CNR1—epilepsy syndrome	2.69e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUNB—epilepsy syndrome	2.69e-05	0.000193	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—IL1B—epilepsy syndrome	2.68e-05	0.000193	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	2.68e-05	0.000193	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PLCB1—epilepsy syndrome	2.68e-05	0.000192	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GABRA5—epilepsy syndrome	2.68e-05	0.000192	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—CASP3—epilepsy syndrome	2.68e-05	0.000192	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUNB—epilepsy syndrome	2.67e-05	0.000192	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CNR1—epilepsy syndrome	2.67e-05	0.000192	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	2.67e-05	0.000191	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PLCB1—epilepsy syndrome	2.66e-05	0.000191	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—epilepsy syndrome	2.64e-05	0.00019	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—epilepsy syndrome	2.63e-05	0.000189	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—epilepsy syndrome	2.62e-05	0.000188	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR7—epilepsy syndrome	2.62e-05	0.000188	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR7—epilepsy syndrome	2.6e-05	0.000187	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ARHGEF9—epilepsy syndrome	2.57e-05	0.000184	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GABRA1—epilepsy syndrome	2.57e-05	0.000184	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC17A7—epilepsy syndrome	2.57e-05	0.000184	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GABRB3—epilepsy syndrome	2.57e-05	0.000184	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HBEGF—epilepsy syndrome	2.55e-05	0.000183	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HBEGF—epilepsy syndrome	2.53e-05	0.000181	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT3—epilepsy syndrome	2.5e-05	0.000179	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—POMC—epilepsy syndrome	2.48e-05	0.000178	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT3—epilepsy syndrome	2.48e-05	0.000178	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—POMC—epilepsy syndrome	2.46e-05	0.000177	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—ADAM10—epilepsy syndrome	2.44e-05	0.000175	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	2.44e-05	0.000175	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—CCL2—epilepsy syndrome	2.43e-05	0.000174	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—ADAM10—epilepsy syndrome	2.42e-05	0.000174	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—CCL2—epilepsy syndrome	2.41e-05	0.000173	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	2.41e-05	0.000173	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC1A2—epilepsy syndrome	2.39e-05	0.000171	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—S100B—epilepsy syndrome	2.31e-05	0.000166	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—S100B—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADK—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PDXK—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GLUD1—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—L2HGDH—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—FAR1—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CERS1—epilepsy syndrome	2.29e-05	0.000164	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SOCS3—epilepsy syndrome	2.28e-05	0.000164	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CDC42—epilepsy syndrome	2.28e-05	0.000164	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GABRB2—epilepsy syndrome	2.28e-05	0.000163	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—VEGFA—epilepsy syndrome	2.27e-05	0.000163	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SOCS3—epilepsy syndrome	2.27e-05	0.000163	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CDC42—epilepsy syndrome	2.26e-05	0.000162	CbGpPWpGaD
Tolvaptan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	2.25e-05	0.000162	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AQP1—epilepsy syndrome	2.24e-05	0.000161	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AVP—epilepsy syndrome	2.21e-05	0.000158	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AVP—epilepsy syndrome	2.19e-05	0.000157	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPV1—epilepsy syndrome	2.18e-05	0.000157	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC8A1—epilepsy syndrome	2.1e-05	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NHLRC1—epilepsy syndrome	2.09e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—EPM2A—epilepsy syndrome	2.09e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PNPO—epilepsy syndrome	2.09e-05	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GAMT—epilepsy syndrome	2.09e-05	0.00015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HES1—epilepsy syndrome	2.09e-05	0.00015	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HES1—epilepsy syndrome	2.07e-05	0.000149	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FYN—epilepsy syndrome	2.03e-05	0.000146	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC1A3—epilepsy syndrome	2.03e-05	0.000146	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AQP4—epilepsy syndrome	2.03e-05	0.000146	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.02e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.02e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FYN—epilepsy syndrome	2.01e-05	0.000145	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—H2AFX—epilepsy syndrome	2.01e-05	0.000144	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MEF2C—epilepsy syndrome	2e-05	0.000144	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—epilepsy syndrome	2e-05	0.000144	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.95e-05	0.00014	CbGpPWpGaD
Tolvaptan—ABCB1—Allograft Rejection—TNF—epilepsy syndrome	1.95e-05	0.00014	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—QDPR—epilepsy syndrome	1.95e-05	0.00014	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CA4—epilepsy syndrome	1.95e-05	0.00014	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCC2—epilepsy syndrome	1.94e-05	0.00014	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.94e-05	0.000139	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NGF—epilepsy syndrome	1.93e-05	0.000138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NGF—epilepsy syndrome	1.91e-05	0.000137	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCR5—epilepsy syndrome	1.88e-05	0.000135	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCR5—epilepsy syndrome	1.86e-05	0.000134	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA13—epilepsy syndrome	1.86e-05	0.000134	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—HTR2A—epilepsy syndrome	1.84e-05	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—COX3—epilepsy syndrome	1.83e-05	0.000131	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HTR2A—epilepsy syndrome	1.82e-05	0.000131	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC6A1—epilepsy syndrome	1.81e-05	0.00013	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—epilepsy syndrome	1.75e-05	0.000125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TSC2—epilepsy syndrome	1.74e-05	0.000125	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGT—epilepsy syndrome	1.74e-05	0.000125	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC6A8—epilepsy syndrome	1.73e-05	0.000125	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—KCNB1—epilepsy syndrome	1.73e-05	0.000125	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PFKL—epilepsy syndrome	1.73e-05	0.000125	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLCO1A2—epilepsy syndrome	1.73e-05	0.000125	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CACNA2D2—epilepsy syndrome	1.73e-05	0.000125	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—TSC2—epilepsy syndrome	1.73e-05	0.000124	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGT—epilepsy syndrome	1.73e-05	0.000124	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—epilepsy syndrome	1.71e-05	0.000123	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—epilepsy syndrome	1.69e-05	0.000122	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—epilepsy syndrome	1.67e-05	0.00012	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—KDR—epilepsy syndrome	1.67e-05	0.00012	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—KDR—epilepsy syndrome	1.66e-05	0.000119	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ABCG2—epilepsy syndrome	1.65e-05	0.000119	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP2A2—epilepsy syndrome	1.61e-05	0.000116	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCB—epilepsy syndrome	1.61e-05	0.000116	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6ST—epilepsy syndrome	1.6e-05	0.000115	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCB—epilepsy syndrome	1.6e-05	0.000115	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6ST—epilepsy syndrome	1.59e-05	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ATIC—epilepsy syndrome	1.59e-05	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UPB1—epilepsy syndrome	1.59e-05	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NEU1—epilepsy syndrome	1.59e-05	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—epilepsy syndrome	1.58e-05	0.000113	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD17B4—epilepsy syndrome	1.53e-05	0.00011	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—epilepsy syndrome	1.5e-05	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GBE1—epilepsy syndrome	1.47e-05	0.000106	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPP1R3C—epilepsy syndrome	1.47e-05	0.000106	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—POMC—epilepsy syndrome	1.47e-05	0.000105	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—POMC—epilepsy syndrome	1.46e-05	0.000105	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—epilepsy syndrome	1.43e-05	0.000103	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—epilepsy syndrome	1.42e-05	0.000102	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—epilepsy syndrome	1.42e-05	0.000102	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PDXK—epilepsy syndrome	1.41e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	1.41e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	1.41e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADK—epilepsy syndrome	1.41e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—FAR1—epilepsy syndrome	1.41e-05	0.000101	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CERS1—epilepsy syndrome	1.41e-05	0.000101	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ASAH1—epilepsy syndrome	1.39e-05	9.95e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLAT—epilepsy syndrome	1.37e-05	9.84e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—STXBP1—epilepsy syndrome	1.35e-05	9.68e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—epilepsy syndrome	1.32e-05	9.48e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NT5E—epilepsy syndrome	1.31e-05	9.44e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALAD—epilepsy syndrome	1.31e-05	9.44e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A1—epilepsy syndrome	1.31e-05	9.39e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.3e-05	9.31e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	1.29e-05	9.26e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	1.29e-05	9.26e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GAMT—epilepsy syndrome	1.29e-05	9.26e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PNPO—epilepsy syndrome	1.29e-05	9.26e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—FGF2—epilepsy syndrome	1.29e-05	9.24e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—epilepsy syndrome	1.28e-05	9.21e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CACNA1A—epilepsy syndrome	1.25e-05	9e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDH7A1—epilepsy syndrome	1.25e-05	9e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ST3GAL3—epilepsy syndrome	1.23e-05	8.81e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RELA—epilepsy syndrome	1.2e-05	8.64e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADSL—epilepsy syndrome	1.2e-05	8.63e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CA4—epilepsy syndrome	1.2e-05	8.61e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—QDPR—epilepsy syndrome	1.2e-05	8.61e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RELA—epilepsy syndrome	1.2e-05	8.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	1.19e-05	8.58e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.18e-05	8.48e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GLUL—epilepsy syndrome	1.18e-05	8.46e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MTOR—epilepsy syndrome	1.17e-05	8.41e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CACNA1D—epilepsy syndrome	1.16e-05	8.31e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—epilepsy syndrome	1.15e-05	8.26e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COX3—epilepsy syndrome	1.13e-05	8.09e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—epilepsy syndrome	1.12e-05	8.05e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.1e-05	7.87e-05	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.09e-05	7.81e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.09e-05	7.8e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TXNRD1—epilepsy syndrome	1.08e-05	7.77e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—epilepsy syndrome	1.08e-05	7.74e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—epilepsy syndrome	1.08e-05	7.72e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PFKL—epilepsy syndrome	1.07e-05	7.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	1.07e-05	7.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	1.07e-05	7.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	1.07e-05	7.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	1.07e-05	7.67e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AVP—epilepsy syndrome	1.07e-05	7.65e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—JUN—epilepsy syndrome	1.05e-05	7.57e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AQP1—epilepsy syndrome	1.05e-05	7.54e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—JUN—epilepsy syndrome	1.05e-05	7.52e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.03e-05	7.37e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—epilepsy syndrome	1.02e-05	7.31e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—epilepsy syndrome	9.95e-06	7.15e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—epilepsy syndrome	9.88e-06	7.09e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NEU1—epilepsy syndrome	9.77e-06	7.02e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UPB1—epilepsy syndrome	9.77e-06	7.02e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ATIC—epilepsy syndrome	9.77e-06	7.02e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—epilepsy syndrome	9.6e-06	6.9e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—KCNJ11—epilepsy syndrome	9.5e-06	6.82e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CHRM3—epilepsy syndrome	9.5e-06	6.82e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SRC—epilepsy syndrome	9.46e-06	6.79e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	9.41e-06	6.75e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SRC—epilepsy syndrome	9.39e-06	6.74e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—epilepsy syndrome	9.21e-06	6.62e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—epilepsy syndrome	9.15e-06	6.57e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	9.08e-06	6.52e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GBE1—epilepsy syndrome	9.08e-06	6.52e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	8.54e-06	6.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	8.31e-06	5.97e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NT5E—epilepsy syndrome	8.1e-06	5.81e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALAD—epilepsy syndrome	8.1e-06	5.81e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCG2—epilepsy syndrome	7.75e-06	5.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	7.72e-06	5.55e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	7.72e-06	5.55e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	7.56e-06	5.43e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2C19—epilepsy syndrome	7.55e-06	5.42e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP11A1—epilepsy syndrome	7.5e-06	5.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADSL—epilepsy syndrome	7.41e-06	5.32e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GLUL—epilepsy syndrome	7.26e-06	5.21e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—epilepsy syndrome	7.15e-06	5.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	7.13e-06	5.12e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2D6—epilepsy syndrome	6.77e-06	4.86e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	6.67e-06	4.79e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AQP1—epilepsy syndrome	6.47e-06	4.65e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—epilepsy syndrome	6.46e-06	4.64e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADRA2A—epilepsy syndrome	6.44e-06	4.63e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—BCHE—epilepsy syndrome	6.42e-06	4.61e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A1—epilepsy syndrome	6.12e-06	4.4e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PLCB1—epilepsy syndrome	6.06e-06	4.35e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—TH—epilepsy syndrome	6.03e-06	4.33e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—epilepsy syndrome	5.88e-06	4.22e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	5.85e-06	4.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	5.85e-06	4.2e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—epilepsy syndrome	5.84e-06	4.19e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—epilepsy syndrome	5.04e-06	3.62e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—epilepsy syndrome	4.97e-06	3.57e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	4.77e-06	3.43e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	4.65e-06	3.34e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	4.62e-06	3.32e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—epilepsy syndrome	4.49e-06	3.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	4.17e-06	2.99e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	3.97e-06	2.85e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BCHE—epilepsy syndrome	3.95e-06	2.84e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGT—epilepsy syndrome	3.94e-06	2.83e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—epilepsy syndrome	3.86e-06	2.77e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	3.77e-06	2.71e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	3.73e-06	2.68e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—TH—epilepsy syndrome	3.72e-06	2.67e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—POMC—epilepsy syndrome	3.32e-06	2.38e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	3.1e-06	2.23e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—epilepsy syndrome	3.06e-06	2.2e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—epilepsy syndrome	3.02e-06	2.17e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	2.98e-06	2.14e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—epilepsy syndrome	2.77e-06	1.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—epilepsy syndrome	2.65e-06	1.9e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGT—epilepsy syndrome	2.43e-06	1.74e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—epilepsy syndrome	2.38e-06	1.71e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—POMC—epilepsy syndrome	2.04e-06	1.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.86e-06	1.34e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	1.63e-06	1.17e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—epilepsy syndrome	1.33e-06	9.55e-06	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—epilepsy syndrome	8.19e-07	5.88e-06	CbGpPWpGaD
